NASDAQ
AN2 Therapeutics, Inc. (ANTX) has a free cash flow growth of -130.58% as of Friday, May 29, 2026. This represents a 1238.15% decrease compared to its 12-month average of -9.76%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.